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1. Introduction 
RNA polymerases (RNAPs) are among the most important cellular enzymes. They are 
present in all living organisms from Bacteria and Archaea to Eukarya and are responsible 
for DNA-dependent transcription. Although in Bacteria and Archaea there is only one 
RNAP, Eukarya possess up to three RNAPs in animals (I, II and III) and five in plants (IV 
and V) [1-2]. All of the RNAPs are evolutionarily related and have common structural and 
functional properties. The minimally conserved structural organization is represented by the 
bacterial enzyme, which contains only 4 subunits (’’), whereas Archaea and 
Eukarya RNAPs are composed of 12 subunits (Rpb1-Rpb12) [3]. In prokaryotes, one RNAP 
transcribes all of the genes into all of the RNAs, however, in eukaryotes, this is achieved by 
three RNAPs. RNAPI transcribes genes that encode for 18S and 28S ribosomal RNAs; 
RNAPIII transcribes short genes, such as tRNAs and 5S ribosomal RNA, and RNAPII 
transcribes all protein-coding genes and genes for small noncoding RNAs (e.g., small 
nuclear RNAs (snRNAs) that are involved in splicing). The largest catalytic subunits of all 
three eukaryotic polymerases share homology among themselves and with the largest 
subunit of bacterial polymerase [4]. Solely the largest subunit of RNAPII (Rpb1) contains an 
unusual evolutionarily conserved carboxy-terminal domain (CTD) [5], which is subjected to 
numerous post-translational modifications of extraordinary importance in gene expression 
regulation [6-8].RNAPII transcription plays a central role in gene expression and is highly 
regulated at many steps, such as initiation, elongation and termination. Furthermore, 
phosphorylation of the Rpb1 CTD is known to regulate all of the transcription steps and 
coordinate these steps with other nuclear events. Prior to mRNA biosynthesis, RNAPII 
proceeds through several steps, such as promoter recognition, preinitiation complex (PIC) 
assembly, open complex formation, initiation and promoter escape. This sequence of events 
is initiated by the binding of gene-specific activators and coactivators, which results in the 
recruitment of basal transcription machinery (i.e., general transcription factors (GTFs): 
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TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH) and RNAPII to promoters [9-11]. Basal 
transcription factors position RNAPII on promoters to form the PIC but also function at later 
steps, such as promoter melting and initiation site selection. Thereafter, initiation proceeds, 
and RNAPII leaves the promoter during promoter clearance and proceeds into processive 
transcript elongation. Finally, when the gene has been fully transcribed, transcriptional 
termination occurs, and RNAPII is released and recycled to reinitiate a new round of 
transcription [12-14]. 
During its passage across a gene, RNAPII must overcome challenges. Initially, the 
polymerase needs to escape from the promoter, and the synthesis of the pre-mRNAs must 
be tightly coupled to its subsequent processing (i.e., capping, splicing, and polyadenylation). 
Then, initiation factors must be exchanged for elongation factors [15], which are thought to 
increase the transcription rate and RNAPII processivity. In fact, recently, there has been an 
extraordinary increase in the number of proteins known to influence transcription 
elongation by avoiding transcriptional arrest, facilitating chromatin passage and mRNA 
processing [16-21], allowing mRNA packaging into a mature ribonucleoprotein (mRNP) and 
controlling mRNP quality and mRNA export [13, 22-28]. Therefore, the discovery of all of 
these factors has provided further evidence that the elongation phase is also highly 
regulated in eukaryotic cells and strictly coordinated with other nuclear processes [12-14].  
2. RNAPII CTD phosphorylation: The CTD code 
During the last two decades, gene expression studies have provided further evidence that 
many steps in gene expression, originally considered distinct and independent, are, in fact, 
highly coordinated, linked and regulated in a complex web of connections [29-30]. The 
central coordinator that directs this regulatory network (i.e., from transcription initiation to 
termination and with pre-mRNA processing) in combination with many other nuclear 
functions is RNAPII, and the carboxy-terminal domain (CTD) of its largest subunit is of 
remarkable importance. CTD phosphorylation regulates and coordinates the entire 
transcription cycle with  pre-mRNA processing, mRNA transport and with chromatin 
remodeling and modification [13]. The CTD, therefore, has a critical integrating role in 
essentially all of the mRNA biogenesis steps, thus, it is subject to a dynamic regulation 
during the transcription cycle (i.e., [21, 31-32]). Therefore, RNAPII phosphorylation is one of 
the key processes in the regulation of transcription specifically and gene expression in 
general; consequently, deciphering the mechanisms that underlie RNAPII phosphorylation 
regulation has become one of the most studied issues in the field of gene expression. 
RNAPII is comprised of 12 subunits (Rpb1-12) that are structurally and functionally 
conserved from yeast to mammals [33-34]. In 1985, the largest subunit of RNAPII, Rpb1, 
from mouse and Saccharomyces cerevisiae, was cloned [4, 35], and its sequence revealed that it 
contained a highly conserved carboxy-terminal domain (CTD). This domain has been 
extensively studied since then and, although it is a simple repetition in tandem of the 
heptapeptide consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 (YSPTSPS); Figure 1), 
the CTD has an extremely complex functionality. The consensus sequence is present in 
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animals, plants, yeast, and in many protists [5, 36-37], and it has been hypothesized that the 
CTD structure has originated through amplifications of a repetitive DNA sequence and that 
the number of repeats appears directly correlated with genomic complexity (Figure 1A; 
[38]). For example, mouse and human CTDs contain 52 repeats [35, 39-40]; the Drosophila 
CTD contains 45 repeats [41]; 25-27 repeats are found in the yeast CTD (Figure 1A; [4]); and 
15 repeats are found in protozoan CTDs [5, 38]. Although the CTD is completely dispensable 
for in vitro transcription, it is required for efficient RNA processing [17, 42]. In fact, the CTD 
is essential for cell viability because its deletion is lethal in mice, Drosophila and yeast, and 
partial truncations or site-specific mutations cause specific growth defects [5, 42].  
 
 
Figure 1. Human and Saccharomyces cerevisiae Rpb1-CTDs.  
Original studies showed that two RNAPII forms can be differentiated in SDS-PAGE gels 
because of the different mobility of Rpb1 [43]. These two forms were termed RNAPIIA and 
RNAPIIO, and they differ in the extent of CTD phosphorylation. RNAPIIA is 
hypophosphorylated [44], and RNAPIIO is hyperphosphorylated [45]. Moreover, both 
forms, IIA and IIO, are functionally distinct because the IIA form is preferentially recruited 
to the promoter and associated with preinitiation complexes [46], whereas RNAPIIO 
functions during elongation, is highly phosphorylated [44] and thus requires de-
phosphorylation to stimulate its recruitment into the PIC complexes and to reinitiate a new 
round of transcription [47]. We currently know that this earlier two-step transcription cycle 
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model that is based on the two RNAPII forms is overly simple. Different phosphorylated 
forms of RNAPII are specific and characteristic of the different steps that occur during the 
transcription cycle [48], and the correct progression of RNAPII through the transcription 
cycle is dependent on changes in the CTD phosphorylation status. Differential CTD 
phosphorylation promotes the exchange of initiation and elongation factors during 
promoter clearance [15], the exchange of elongation and 3’-end processing factors at 
termination [49], as well as RNAPII recycling [50] and, moreover, links pre-mRNA 
processing and other nuclear events with transcription [17, 42]. Therefore, the CTD 
phosphorylation cycle is very complex. It is widely known that the three serines (i.e., Ser2, 
Ser5, and Ser7) [7, 51], the tyrosine [52-53] and the threonine [54] in each repeat can be 
phosphorylated. Additionally, both proline residues can be isomerized by a prolyl 
isomerase [55]. Moreover, glycosylation of serines and threonine can also occur [8], and in 
human cells, the CTD can be methylated at some of the degenerate repeat sites [56]. The 
multitude of possible CTD modifications, especially Ser phosphorylations, in combination 
with the numerous repetitions, gives rise to a wide range of variations (i.e., phosphorylation 
patterns) that have been termed the “CTD code” (Figure 2) [6-8].  
 
Figure 2. The CTD Code. Only Ser (S) and Thr (T) phosphorylation sites have been considered. CTD 
glycosylation has not been considered [57] because this modification is mutually exclusive of 
phosphorylation [8]. n: number of consensus repetitions.  
The RNAPII CTD code determines and coordinates the timely sequential recruitment of 
required specific factors during the transcription cycle. Therefore, the CTD functions as a 
scaffold that coordinates mRNA biogenesis, such as transcription initiation [58], promoter 
clearance [59], elongation [60], and termination [31, 61-62], as well as RNA processing [17, 
21, 30] and snRNA and snoRNA gene expression [63-65] by recruiting the appropriate set of 
factors when required during active transcription. These factors recognize CTD 
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phosphorylation patterns either indirectly or directly by contacting phosphorylated 
residues. Among the CTD-associated factors are export and histone modifier factors and 
DNA repair factors [21]. 
2.1. Ser2P and Ser5P, and to a lesser extent, Ser7P, are the main determinants of 
the CTD code 
To determine precisely which serine residues are phosphorylated in a particular repeat has 
been challenging because of the numbers of phospho-acceptor amino acid residues and 
consensus motif repetitions (Figure 1). However, studies involving chromatin 
immunoprecipitation with specific monoclonal antibodies have provided evidence that 
differential phosphorylation of the Ser residues coincides with the temporal and spatial 
recruitment of different factors [8, 32, 48, 66-67]. In fact, these antibodies have been largely 
used to decipher and characterize the role of CTD phosphorylation during the transcription 
cycle and in gene expression regulation [8, 32, 68]. Antibodies that selectively recognize 
either Ser2 or Ser5 phosphorylation (i.e., Ser2P or Ser5P, respectively) were the first residues 
to be described [66]; phosphorylation of these two residues has been extensively studied, 
and they have been considered as the two main determinants of the CTD code [6]. It is 
widely known that CTD phosphorylation switch from Ser5 to Ser2 during the course of 
transcription and is subject to a dynamic regulation during the whole transcription cycle 
[69-71]. The level of Ser5 phosphorylation peaks early in the transcription cycle and remains 
constant or decreases as RNAPII progresses to the 3′ end of the gene  (Figure 3); [48, 67, 72]). 
In contrast, Ser2 phosphorylation is the predominant modification in the coding and 3′-end 
gene regions and occurs simultaneously with productive elongation [31, 48, 73]. On the 
other hand, de-phosphorylation of Ser5 occurs during the initiation-elongation transition 
and throughout the entire elongation step, whereas Ser2 de-phosphorylation occurs at the 
end of transcription to recycle the polymerase and reinitiate a new round of transcription. 
Therefore, reversible phosphorylation/de-phosphorylation of the CTD plays a significant 
role in modulating the transcription cycle [31-32]. 
Most recently, the use of new anti-CTD monoclonal antibodies has demonstrated that Ser7, 
which is the most degenerate position of the CTD [41], can be phosphorylated during the 
transcription of snRNA genes and protein-coding genes [64, 68, 74]. Subsequently, this mark 
increases the complexity of the CTD code [7-8]. Ser7 phosphorylation is mediated by the 
same kinase [74-75], although, at least in Saccharomyces cerevisiae, Ser7P appears not to be 
dephosphorylated by the same Ser5 phosphatase (see below) [76].The first study on Ser7 
phosphorylation provided further evidence that this modification is functionally important 
for transcription and processing of snRNAs [8, 64] and hypothesized that the CTD code 
could be gene-transcription dependent. In mammals, Ser7P peaks at the promoter region of 
snRNA genes but is enhanced toward the 3′ end of protein-coding genes [68].  Recent 
genome-wide distribution studies in yeast have provided further evidence that Ser7P in 
protein coding genes occurs early during transcription initiation and is maintained during 
the entire transcription cycle. In fact, Ser7P is not only maintained, but it is also generated de 
novo during transcription elongation. Additionally, it has been hypothesized that Ser7 
phosphorylation could facilitate elongation and suppress cryptic transcription [77]. 
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Figure 3. RNAPII CTD phosphorylation profile in Sacharomyces cerevisiae. During transcription 
initiation and promoter escape RNAPII CTD is phosphorylated on Ser5 (Ser5P) [48, 78]. Concurrently, 
Ser7 is phosphorylated (Ser7P), establishing a bivalent mark at both protein-coding and noncoding 
genes [74-76]. Shortly after promoter dissociation, Ser5P is rapidly removed while phosphorylated Ser2 
(Ser2P) and Ser7P continue to accumulate [70, 77]. Finally, all CTD marks are rapidly removed at the 
end of transcription, and the hypophosphorylated RNAPII (in grey) is ready to assemble into the pre-
initiation complex and re-initiate transcription [73, 79-80]. Small circles represent phosphorylated serine 
residues (green cirlces for Ser5P, blue circles for Ser7P and red circles for Ser2P). Differently colored big 
circles represent the distinct phosphorylated forms of RNAPII during initiation, elongation and 
termination. TSS: transcription start site; p(A): polyadenylation site. 
2.2. Tyrosine 1 and Threonine 4 can also be phosphorylated 
Tyrosine 1 (Tyr1) is evolutionarily conserved and present in all of the 52 repeats of the 
mammalian CTD, and in all of the 26-27 repeats of the yeast CTD. Although, it is well 
known that Tyr1 is susceptible to phosphorylation by tyrosine kinases in vivo [52-53] and 
that Tyr1 mutations are lethal in yeast [81], the function of this modification is unknown. 
Additionally, threonine 4 (Thr4) is also subjected to phosphorylation, at least in mammalian 
and in yeast cells [54, 82], and recently it has been demonstrated that phosphorylation of the 
Thr4 residues is required specifically for histone mRNA 3' end processing, which facilitates 
the recruitment of 3' processing factors to histone genes, and is evolutionarily conserved 
from yeast to human [54]. 
In mammals, there is an important degeneracy at some positions in the CTD, mainly in most 
of the carboxy-terminal repeats. Thus, the last repeat of the CTD is followed by a conserved 
10 amino acid extension (Figure 1; [5]) that contains a constitutive site for the casein kinase 
(CK) II site [83]. Though deletion of this extension results in degradation of the CT, and 
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effects in transcription and pre-mRNA processing [83-84], mutation of the CKII target site 
does not affect RNAPII CTD stability. Additionally, this extension is required for the 
phosphorylation of Tyr1 by c-Abl in mammals and it has been suggested that Tyr1 
phosphorylation could be involved in functions specific of these higher eukaryotes [85]. 
Finally, non-consensus residues, such as lysine and arginine, are also present in the CTD, 
and they could be potentially modified by acetylation, ubiquitylation, sumoylation (lysine 
residues) and methylation (lysine and arginine residues) [86]. Therefore, the possibilities of 
CTD modifications are enormous, and only some of the modifications have been 
demonstrated to influence, while interacting with numerous factors, different aspects of 
gene expression. 
3. Modifying enzymes: Kinases and phosphatases 
Most of what is known concerning CTD-protein interactions, and in particular RNAPII 
CTD modifying enzymes, is derived from animal and yeast models, especially 
Saccharomyces cerevisiae, since the consensus sequence and repetitive structure of the CTD 
in addition to the CTD-modifying enzymes are highly conserved across a wide range of 
organisms. A number of kinases and phosphatases that target the CTD have been 
described and extensively studied (Tables 1 and 2, and reference therein). Recent genome-
wide distribution studies of the CTD modifications in yeast have provided further 
evidence that complex interplay exists between these enzymes (i.e., kinases, phosphatases 
and isomerase), which coordinate a universal RNAPII CTD cycle [69]. These modifying 
enzymes alter specific serine residues within the CTD repeats and have distinct and 
specific functions along the transcription cycle. Although the catalytic mechanisms of 
CTD kinases and phosphatases are known, the basis for their specificity remains 
incompletely understood [87-88]. 
Below, in figure 4, we will highlight the most relevant features and functions of CTD kinases 
and phosphatases, with special emphasis on the budding yeast enzymes because extensive 
studies on RNAPII CTD phosphorylation have been performed on that organism, and most 
of these enzyme complexes are evolutionarily conserved.  
3.1. RNAPII CTD kinases 
The CTD is phosphorylated by members of the cyclin-dependent kinase (CDK) family, 
which usually consists of a catalytic and a cyclin subunit. Although CDKs are cell cycle 
regulators, several members of this family have direct functions in RNAPII activity 
regulation [39, 88]. All these kinases are members of multiprotein transcription regulatory 
complexes and, in mammals, the best known are Cdk7/CycH, Cdk8/CycC and Cdk9/CycT; 
recently, Cdk12/CycK has been characterized as a new CTD kinase [89]. These kinases are 
evolutionarily conserved, and the following four complexes with kinase activity have been 
identified in the well-known yeast model Saccharomyces cerevisae: Kin28/Ccl1, Srb10/Srb11, 
Bur1/Bur2 and Ctk1/Ctk2 (Table 1).  
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KINASES SPECIFICITY FUNCTION 
 
REFERENCES 
 
 
 
ySrb10 / Srb11 
hCdk8 / CycC 
 
CTD-Ser2 
CTD-Ser5 
 
Other substrates 
Bdf1 and Taf2, Med2 
Gcn4, Msn2, Ste12, 
Gal4 
 
 
TFIIH inhibition 
PIC inhibition / activation 
Scaffold complex formation 
SAGA-dependent transcription 
 
 
[90-94] 
 
 
 
 
yKin28 / Ccl1-
Tfb3 
hCdk7 / CycH 
 
 
CTD-Ser5 
CTD-Ser7 
 
Other substrates 
Med4 
Rgr1/Med14 
 
Promoter scape 
Scaffold complex formation  
Capping complex recruitment 
Bur1 activity stimulation 
Set1/COMPASS recruitment 
Elongation factor Paf1C recruitment 
SAGA complex recruitment 
snRNA 3’ processing 
Promoter-pausing  
Gene looping 
 
 
[64, 72, 74-76, 90, 94-
100] 
 
 
 
yBur1 / Bur2 
hCdk9 / CycT 
 
CTD-Ser2 
CTD-Ser5 
CTD-Ser7 
CTD-Thr4 
 
Other Substrates 
hDSIF (ySpt5),   
Rad6/Bre1 
 
 
Ctk1 activity stimulation 
Elongation 
PAF complex recruitment 
H3K4 methylation 
H2B monoubiquitination 
Histone genes 3’-end processing 
 
[54, 99, 101-104] 
 
 
yCtk1 / Ctk2-
Ctk3 
hCdk12 / CycK 
 
 
CTD-Ser2 
 
Other Substrates 
Rps2 
 
RNAPII release from basal initiation            
factors 
3’-processing factors recruitment 
Transcription termination 
Spt6 recruitment 
H3K36 methylation 
Translation elongation 
 
 
[16, 49, 89, 105-112]  
 
 
Table 1. RNAPII CTD kinases. Mammalian and Saccharomyces cerevisiae kinases are shown. 
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Figure 4. The levels of CTD phosphorylation are precisely modulated during the whole transcription 
cycle by the action of evolutionary conserved kinases and phosphatases. The level of Ser5 
phosphorylation peaks early in the transcription cycle due to the action of Kin28 (Cdk7 in human) and 
remains constant or decreases as RNAPII progresses to the 3′ end of the gene [48, 67, 72]. In contrast, 
Ser2 phosphorylation is the predominant modification in the gene body and towards the 3′ end, and 
occurs concurrently with productive elongation [31, 48]. Ctk1 is the principal kinase responsible for Ser2 
phosphorylation in the body of the genes [16, 73]. In addition to Ctk1, the Bur1/Bur2 kinase complex 
phosphorylates Ser2 when RNAPII is near the promoter and stimulates Ser2 phosphorylation by Ctk1 
during elongation [99]. Several CTD-phosphatases have been shown to specifically de-phosphorylate 
Ser5P (Ssu72 and Rtr1), Ser2P (Fcp1) and Ser7 (Ssu72) to promote the initiation-elongation transition, 
elongation, termination, and RNAPII recycling [50, 73, 79, 167, 182]. Srb10 was demonstrated to 
phosphorylate the RNAPII CTD prior to PIC assembly, negatively regulating transcription initiation 
[92]. 
3.1.1. Pre-initiation and Initiation RNAPII CTD kinases 
Cdk8/CycC and Srb10/Srb11 
Human Cdk8/CycC and yeast Srb10/Srb11 are part of the CDK-module of Mediator [113], a 
large complex of 25-30 proteins that is structured in 4 sub-complexes or modules that act as 
a molecular bridge between DNA-binding transcription factors and RNAPII [114-115]. 
Mediator is required for the expression of nearly all RNAPII transcribed genes [116]. 
Cdk8/Srb10 is part of the CDK-module (Cdk8, cyclin C, MED12 and MED13 in mammals; 
Srb8, 9, 10 and 11 in yeast), which dynamically associates with Mediator [93, 117]. Although 
Cdk8/Srb10 can phosphorylate Ser2 and Ser5 of the CTD repeats in vitro [90, 92-94, 109, 113], 
the in vivo relevance of Cdk8/Srb10 remains to be defined. In fact, several studies have 
provided evidence that Srb10/11 can have both negative [116] and positive [118] effects on 
gene expression in vivo. Srb10 was demonstrated to phosphorylate the RNAPII CTD prior to 
PIC assembly, negatively regulating transcription initiation (Figure 4; [92]). Notably, human 
Cdk8 represses transcription via phosphorylation and inactivation of the cyclin H subunit of 
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TFIIH, which is the Cdk7 partner [90]. However, subsequent work showed that Srb10 
functions in association with Kin28 (hCdk7) to promote RNAPII re-initiation [94]. Following 
PIC formation and an initial round of transcription, it is thought that subsequent rounds of 
RNAPII binding and promoter clearance are facilitated via a “scaffold complex” that is 
composed of a subset of Mediator subunits and GTFs (except TFIIB and TFIIF) that remains 
bound at the promoter [119]. Therefore, Kin28 and Srb10 have overlapping positive 
functions in promoting transcription and in the formation of the scaffold complex [94]. Srb10 
phosphorylates two subunits of the general transcription factor TFIID (Bdf1 and Taf2) at the 
PIC; however, the role of these phosphorylation events has not yet been defined. Moreover, 
Srb10 phosphorylates and inactivates some transcription factors [120-122]  by triggering 
their nuclear export or degradation [123-124] and phosphorylates and enhances the activity 
of others (Table 1). In summary, the in vivo relevance of RNAPII phosphorylation by 
Cdk8/Srb10 and its role in gene expression have yet to be elucidated. 
Cdk7/CycH  and Kin28/Ccl1-Tfb3 
The Cdk7/cyclin H complex in mammals and its homolog in Saccharomyces cerevisiae, 
Kin28/Ccl1, are part of the TFIIH general transcription factor. In yeast, Kin28 is found 
associated with a third subunit (Tfb3) to form a trimer, called TFIIK (Kin28-Ccl1-Tfb3) 
within TFIIH [125]. Mammalian Cdk7 was isolated as a RNAPII CTD kinase that possesses 
Cdk-activating kinase (CAK) activity [126-128], whereas in yeast, Kin28 lacks this activity 
[129]. The CAK activity is fulfilled by a different kinase, Cak1 [130-131]. Cdk7 and Kin28 are 
both essential for cell viability [132], and the in vivo function of Kin28 has been extensively 
studied in yeast. Cdk7/Kin28 is the primary kinase that phosphorylates the CTD within a 
transcription initiation complex (Figure 4). Cdk7/Kin28 has been demonstrated to 
phosphorylate both Ser5 and Ser7 in vitro and in vivo [72, 74-76, 92]. Phosphorylation on Ser5 
by Cdk7/Kin28 is thought to disrupt the stable interactions between the CTD and PIC 
components, thereby permitting the polymerase to release from the promoter and 
commence productive transcript elongation [92, 133-134]. Ser5 phosphorylation by 
Cdk7/Kin28 is required for the recruitment of the mRNA-capping complex [72, 135-137] and 
nuclear cap-binding complex (CBC) [100] to nascent transcripts and for co-transcriptional 
recruitment of elongation factor Paf1C [138], histone H3-lysine 4 methyltransferase complex 
(SET1/COMPASS) [98], and histone acetyltransferase complex SAGA [97]. 
Additionally, yeast Kin28 phosphorylates two subunits of Mediator (i.e., Med4 and 
Rgr1/Med14), and although the functionally of these modifications is unknown, it has been 
demonstrated that Mediator significantly enhances the phosphorylation of RNAPII CTD by 
Kin28 [94, 96]. In fact, in vitro assembly of TFIIH into a pre-initiation complex requires 
Mediator [139], and following transcription initiation, phosphorylation of Ser5 by Kin28 
parallels with the release of Mediator from the CTD of RNAPII as promoter clearance occurs 
[80]. 
As discussed above, in yeast, Kin28 and Srb10 have overlapping functions in promoting 
transcription, PIC dissociation and subsequent scaffold complex formation [94]. Genetic 
analysis has provided further evidence that Kin28 and Srb10 are not redundant because only 
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Kin28 is essential for growth, and Srb10 is much less processive in terms of phosphorylation 
than Kin28 [140]. It is clear that Kin28 is the primary kinase responsible for the high level of 
phosphorylation of RNAPII during initiation [48, 67, 94, 141]. In fact, one essential role of 
Kin28 that Srb10 does not have is the stimulation of pre-mRNA processing. However, what 
appears clear, at least in yeast, is that PIC dissociation is dependent on the kinase activities 
of Kin28 and Srb10. Additionally, another function of RNAPII CTD Ser5 phosphorylation by 
Kin28 is the enhancement of Bur1/Bur2 recruitment and Ser2 CTD phosphorylation near the 
promoters [99]. Moreover, it has recently been demonstrated that TFIIH kinase places 
bivalent marks on the CTD, thereby phosphorylating Ser7 during transcription initiation 
[74-75]. 
3.1.2. RNAPII CTD elongating kinases 
Cdk9/CycT and Cdk12/CycK 
Eukaryotic organisms possess many factors that regulate transcriptional elongation; among 
these factors is Cdk9 kinase, which is the catalytic subunit of the positive transcription 
elongation factor b (P-TEFb) that controls the elongation phase of transcription by RNAPII in 
mammals and Drosophila melanogaster [12]. Cdk9 is the major Ser2 kinase, but it also 
contributes to Ser5 phosphorylation in vitro and in vivo during the initiation-elongation 
transition and the polymerase release of promoter-proximal pausing [109, 142]. Cdk9 activity 
is also required for efficient coupling of transcription with pre-mRNA processing [108]. 
Additionally,  very recently, it has been shown that Thr4 is phosphorylated by Cdk9 [54]. 
In higher eukaryotes, the transcription factor P-TEFb not only regulates CTD 
phosphorylation, but it also inhibits the action of transcriptional repressors and is required 
for the association of several elongation factors with the transcribing polymerase. P-TEFb 
also targets DRB sensitivity-inducing factor (DSIF) and negative elongation factor (NELF) 
[142-144] (Table 1). Thus, P-TEFb promotes transcription by the following two different 
mechanisms: inhibiting the action of transcriptional repressors and phosphorylating the 
CTD during transcription elongation. Until recently, it was believed that Cdk9 was the only 
CTD Ser2 kinase in higher eukaryotes. In fact, Cdk9 can reconstitute the activity of both S. 
cerevisiae Ser2 CTD kinases, Bur1 and Ctk1. However, it has recently been demonstrated that 
Drosophila have one ortholog of yeast Ctk1, Cdk12, whereas humans have two, Cdk12 and 
Cdk13; only Cdk12 has been clearly demonstrated to be an elongating CTD kinase [89, 145]. 
Notably and similarly, fission yeast Schizosaccharomyces pombe has the following two Ser2 
elongating kinases: Lsk1 (ScCtk1) and Cdk9 (ScBur1) [146]. 
Bur1/Bur2 
Bur1 kinase and its cyclin, Bur2, form an essential CDK in S. cerevisiae involved in transcription 
elongation [147-148]. Although Bur1 and Ctk1 kinase complexes appear to functionally 
reconstitute the activity of P-TEFb in yeast [149], Bur1 is more related in sequence and 
functionally to mammalian P-TEFb than Ctk1 [147, 149], and as we have discussed, it is clear 
that Cdk12 is the functional equivalent of yeast Ctk1 [89, 145]. Bur1 can phosphorylate Ser2 
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and Ser5 [99, 147, 150] [151], and although it was first demonstrated to show some preference 
for Ser5 and to be less active than Ctk1 or Kin28 [147], later studies provided evidence that 
Bur1 interacts with the RNAPII CTD and phosphorylates at Ser2. In fact, Bur1 phosphorylates 
elongating RNAPII molecules that have been previously phosphorylated at Ser5 and are 
located near the promoter during early transcription elongation (Figure 4, and [99]. Thus, it 
has been hypothesized that Bur1/Bur2 is recruited to RNAPII, whose repeats are 
phosphorylated on Ser5 to enhance phosphorylation on Ser2 by Ctk1. Consistent with it, Bur1 
produces the Ser2 phosphorylated residues that remains when Ctk1 is inactivated [152]. Bur1 
also stimulates transcription elongation as its mammalian homologue P-TEFb [150, 152], and 
mutations on BUR1 cause sensitivity to drugs that are known to affect transcription elongation 
(e.g., 6-azauracil) [147, 150]. More recently, a chemical-genomic analysis has provided further 
evidence that Bur1 also phosphorylates Ser7 in the body of the genes [77].  
Bur1 shares another function with the mammalian and Schizosaccharomyces pombe Cdk9 [142, 
153]. Bur1 kinase activity is important for the in vivo phosphorylation of the elongation factor 
Spt5 (mammalian DSIF) [102, 154]. Spt5 contains a carboxy-terminal domain that consists of 
approximately 15 repeats (CTR) that are similar to the RNAPII CTD [102], which is subject to 
phosphorylation. The Spt5-CTR is required for efficient elongation by RNAPII and for chromatin 
modifications in transcribed regions (see below). Thus, Spt5 phosphorylation mediates, at least in 
part, Bur1 kinase roles on transcription elongation and histone modifications [154].  
Ctk1/Ctk2-Ctk3 
Ctk1 was originally identified as the kinase subunit of the yeast CTDK-I complex that 
catalyzes phosphorylation of the RNAPII CTD [155]. Ctk2 is the cyclin, and the Ctk3 
function remains unknown. Ctk1 is the principal kinase that is responsible for CTD-Ser2P 
during transcription elongation, which is coincident with reduced Ser5P [73, 156]. Although 
Ctk1 is not directly involved in transcription elongation [16, 18, 157], it associates with 
RNAPII throughout elongation [49], and the kinase activity of Ctk1 is required for the 
association of polyadenylation and termination factors [16] and histone modification factors 
[158]. Additionally, Ctk1 interacts genetically as well as biochemically with the TREX 
complex [159], which couples transcription elongation to mRNA export [160]. Moreover, 
Ctk1 promotes the dissociation of basal transcription factors from elongating RNAPII, early 
during transcription, however, kinase activity is not required [105].  
In addition to its functions in transcribing gene coding proteins, Ctk1 is involved in RNAPI 
transcription, interacts with RNAPI in vivo [161], and it is required for the integrity of the 
rDNA tandem array [162]. All of these studies suggest that Ctk1 might participate in the 
regulation of distinct nuclear transcriptional machineries. Additionally, it has been 
demonstrated that Ctk1 is required for DNA damage-induced transcription [163], and notably, 
that Ctk1 has a role in the fidelity of translation elongation in the cytoplasm [110, 164]. 
3.2. RNAPII CTD phosphatases 
Dynamic de-phosphorylation of Ser2P and Ser5P make a significant contribution to changes 
in CTD phosphorylation patterns during the transcription cycle and is essential for RNAPII 
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recycling [8, 31]. Dephosphrylation is achieved by several CTD phosphatases (Table 2). 
Initially, only one phosphatase was identified, Fcp1, which is required for Ser2P de-
phosphorylation, transcription elongation and RNAPII recycling to initiate new rounds of 
transcription [47, 165]. Two other CTD phosphatase were later identified in yeast, Ssu72, a 
component of the mRNA 3' end processing machinery [79, 88, 166] and Rtr1 [167]. In 
mammals, in addition to Fcp1, there are other CTD phosphatases, i.e., the small phosphatase 
SCP1 [168] and RPAP2, which is the human homolog of Rtr1 [169]. Briefly, Fcp1 
dephosphorylates Ser2P [73]; Ssu72 dephosphorylates Ser5P and Ser7P [50, 69]; and Rtr1 in 
yeast and SCP1 in mammals specifically dephosphorylate Ser5P [79, 167-168]. 
Rtr1 / RPAP2 
Chromatin immunoprecipitation studies have provided further evidence that the increase in 
Ser2P occurs as transcription progresses through the gene and follows Ser5P de-
phosphorylation. Rtr1 in yeast was identified as the RNAPII CTD phosphatase driven the 
Ser5-Ser2P transition at the 5’ regions of the transcribed genes. Rtr1 genetically interacts 
with the RNAPII machinery, and Rtr1 deletion provokes global Ser5P accumulation in 
whole-cell extracts and Ser5P association throughout the coding regions [167, 171]. RPAP2 
was identified in a systematic analysis carried out to determine the composition and 
organization of the soluble RNAPII machinery [169], and as in the case of Rtr1, Ser5P levels 
increase in vivo when RPAP2 is knocked down. Additionally, RPAP2 depletion affects 
snRNA gene expression as it does mutations of the Ser7 residue [64]. In fact, Ser7P recruits 
the 3’-end processing Integrator complex and RPAP2 to drive Ser5 de-phosphorylation of 
RNAPII CTD during the transcription of snRNA genes [170, 183]. Recently, a model has 
been proposed in which RPAP2 recruitment to snRNA genes through CTD-Ser7P triggers a 
cascade of events that are critical for proper gene expression [170]. 
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Positive regulator of RNAPII transcription  
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CTD-Ser5P 
Transition from initiation / capping to processive 
transcript elongation. 
 
[168] 
Table 2. RNAPII CTD phosphatases. Human and Saccharomyces cerevisiae phosphatases are shown. 
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Ssu72 
Ssu72 was first described as a Ser5P phosphatase and recently as a Ser7P phosphatase [50, 
69]. In fact, Ssu72 was originally identified as functionally interacting with the general 
transcription factor TFIIB [184-185]. Afterward, it was demonstrated that Ssu72 is part of the 
cleavage and polyadenylation factor (CPF) with a role at the 3’-end of genes [166, 175]. In 
fact, Ssu72 is crucial for transcription-coupled 3’-end processing and termination of protein-
coding genes [175, 186-187]. Later, Ssu72 was characterized as a Ser5P phosphatase [79] and 
a potential tyrosine phosphatase [188] and, most recently, it has been demonstrated that 
Ssu72 is also a Ser7 phosphatase [50, 69]. A genome-wide distribution analysis of Ssu72 has 
demonstrated two peaks of association (Figure 4): a low peak at the 5’-end of genes and a 
higher peak at the cleavage and polyadenylation site or immediately after it [50]. In 
agreement with it, Ssu72 dephosphorylates RNAPII CTD following cleavage and 
polyadenylation and recycles the terminating RNAPII, giving rise to a hypophosphorylated 
polymerase. In fact, inactivation of Ssu72 leads to the accumulation of Ser7P marks that 
avoids RNAPII recruitment to the PIC, and therefore inhibits transcription initiation, which 
results in cell death [50]. In other words, Ssu72 is critical for transcription termination, 3’-
end processing and RNAPII recycling to restart a new round of transcription. Additionally, 
it has been shown that Ssu72 has a function in gene looping [172]. In a screen looking for 
mammalian retinoblastoma tumor suppressors, a human homolog of yeast Ssu72 was 
identified. As in yeast, mammalian Ssu72 associates with TFIIB and the yeast 
cleavage/polyadenylation factor Pta1, and exhibits intrinsic phosphatase activity [176]. The 
crystal complex structure that is formed by human symplekin (Pta1 in yeast), hSsu72 and a 
CTD phosphopeptide has been elucidated, and hSsu72 was demonstrated to have a function 
in coupling transcription to pre-mRNA 3'-end processing [187]. 
Fcp1 / SCP1 
Fcp1 was the first discovered CTD phosphatase and is highly conserved among eukarya [177, 
189-191]. It directly de-phosphorylates RNAPII, and its activity is stimulated in vitro by TFIIF 
and inhibited by TFIIB [73, 177-178]. Fcp1 is essential for cell viability and for transcription in 
yeast [177-178] and preferentially dephosphorylates Ser2P [73, 192]. Fcp1 has two essential 
domains: an FCP homologous domain near the amino-terminus and a downstream BRCA1 
carboxy-terminal (BRCT) domain [87]. Higher eukaryotes have additional small CTD 
phosphatases (SCPs) that contain only the FCPH domain characteristic of the Fcp1 proteins. 
However, SCP1 preferentially catalyzes Ser5P de-phosphorylation and is especially active on 
RNAPII molecules that have been phosphorylated by TFIIH [168].  
Gene transcription is decreased in cells lacking Fcp1 function, and fcp1 mutants exhibited a 
general accumulation of hyperphosphorylated RNAPII in whole-cell extracts, and 
specifically in the gene coding regions [178]. Fcp1 also has the ability to stimulate RNAPII 
transcript elongation in vitro independent of its phosphatase activity [182], which suggests 
that it associates with and modulates elongating RNAPII. In agreement with this, chromatin 
immunoprecipitation studies have demonstrated that Fcp1 associates with the promoter and 
coding region of active genes in vivo [73]. Recent genome-wide studies have provided 
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further evidence that Fcp1 associates with genes from promoter to 3’-end regions, showing 
the highest association of Fcp1 with the cleavage and polyadenylation site. This association 
occurs after Bur1 and Ctk1 have dissociated, which permits Fcp1 to completely 
dephosphorylate all the remaining Ser2P residues ([50], Figure 4). Fcp1 is also responsible 
for de-phosphorylation of RNAPII following its release from DNA [165]. Fcp1 association 
with genes at the cleavage polyadenylation site overlaps with Ssu72 association, whereas 
this overlapping does not exist at the 5’ and coding regions (Figure 4). This fact indicates 
that CTD de-phosphorylation may be coupled at the 3’-ends, and it has been hypothesized 
that Ssu72 activity may be important for Fcp1 function, thereby coupling Ser2P de-
phosphorylation to the removal of Ser5P and Ser7P [69]. 
4. Other factors influencing RNAPII CTD phosphorylation  
Although many factors can have effects on CTD phosphorylation, we will highlight the 
following two that we believe are of significant relevance: the prolyl isomerases hPin1/yEss1 
and the structure of the RNAPII itself. In addition, we will describe the role of ySub1 in CTD 
phosphorylation, because it has been extensively studied by us.   
4.1. hPin1 / yEss1 
The CTD can adopt either cis- or trans-conformations, which can significantly affect its 
modification, especially its phosphorylation. Peptidyl prolyl isomerases (PPIases) are 
enzymes that accelerate the rates of rotation about the peptide bond preceding proline and 
are important for protein folding and regulation of dynamic cellular processes [193-194]. Pin1 
in mammals and Ess1 in S. cerevisiae are RNAPII CTD PPIases. Phosphorylated Ser2 and Ser5 
match with the pSer-Pro sequence that is recognized by Pin1, and the CTD appears to be its 
principal target of regulation [195-196]. Pin1 has specificity for phosphorylated Ser/Thr-Pro 
sequences, and it modulates RNAPII activity during cell cycle at least in part by regulating 
RNAPII CTD phosphorylation levels [195]. Yeast Ess1 physically interacts with the CTD [55, 
197], and it preferentially binds and isomerizes in vitro Ser5P residues [198]. Although Pin1 
stimulates RNAPII CTD hyperphosphorylation, which results in transcription repression and 
inhibition of mRNA splicing [195-196], in vivo studies have proposed that Ess1 promotes 
RNAPII CTD de-phosphorylation. In any case, both isomerases have important functions in 
transcription. Therefore, initiation-elongation transition is inhibited by Pin1 [196], whereas 
Ess1 affects multiple steps, such as initiation, elongation, 3′-end processing, and termination 
[197, 199-201]. In fact, it has been demonstrated that Ess1 promotes Ssu72-dependent function 
by creating the CTD structural conformation that is recognized by Ssu72 [202], and recently it 
has been confirmed that isomerization is a key regulator of RNAPII CTD de-phosphorylation 
at the end of genes [69].  
4.2. RNAPII structure and Rpb1-CTD localization 
The structure of the complete 12-subunit RNAPII (Rpb1-12) is known [203-204]. Rpb4 and 
Rpb7 subunits form a conserved sub-complex that is conserved in all three eukaryotic RNA 
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polymerases and archaea RNAP [205-206]. Crystal structures of the Rpb4/7 heterodimer in 
the context of the complete RNAPII complex localized it in the proximity of the Rpb1-CTD 
[203, 207], and biochemical and genetic studies suggest that Rpb4/7 might have a function in 
the recruitment of some CTD-binding proteins to transcribing RNAPII. Moreover, it is 
possible that this sub-complex, Rpb4/7, would regulate the access of CTD modifying 
enzymes during the whole transcription cycle [203, 207, 209-212]. Actually, structural 
studies have provided further evidence that the CTD extends from the RNAPII core enzyme 
near the RNA exit channel [204], where it is ideally located to bind and be affected by the 
action of a multitude of factors, among them kinases, phosphatases and isomerases. In fact, 
in yeast, the isopropylisomerase Ess1 and the phosphatase Fcp1 are associated with Rpb7 
and Rpb4, respectively [55, 87, 208]. 
4.3. The ssDNA binding protein Sub1 as a general regulator of transcription 
Sub1 is an ssDNA binding protein that has been implicated in several steps of mRNA 
metabolism, such as initiation, transcription termination and 3’-end processing [186, 213-
215]. Sub1 was originally described as a transcriptional stimulatory protein that is 
homologous to the human positive coactivator PC4, which physically interacts with 
activators and components of the RNAPII basal transcription machinery [216-220]. Sub1 
genetically and physically interacts with TFIIB [214-215, 221], and several functions have 
been proposed for Sub1 that include stimulating PIC recruitment and promoter escape. In 
fact, most recently, using a quantitative proteomic screen to identify promoter-bound PIC 
components, Sub1 was identified as a functional PIC component that is associated with 
RNAPII complexes [225]. In addition, we have recently demonstrated that Sub1 globally 
regulates RNAPII CTD phosphorylation (Figure 5, [222]) and that it is a bona fide elongation 
factor that influences transcription elongation rates (García and Calvo, unpublished results). 
Although it has been broadly studied, and several functions have been hypothesized for 
Sub1 [213, 215, 222-225]; however, the exact mechanism by which Sub1 functions in 
transcription remains unclear. Sub1 globally regulates RNAPII-CTD phosphorylation 
during the entire transcription cycle by modulating, albeit differentially, the activity and 
recruitment of CTD modifying enzymes [222, 224]. We have proposed a model showing 
how Sub1 might function to globally regulate RNAPII CTD phosphorylation (Figure 5). In 
wild-type cells (wt), non-phosphorylated Sub1 joins the promoter (possibly via TFIIB; [214-
215, 221]), contacting the promoter via its DNA binding domain. At that point, Sub1 
interacts with the Cdk8-Mediator complex, helping to maintain the PIC in a stable but 
inactive conformation. Sub1 is then phosphorylated (possibly by the action of kinases at the 
PIC, similarly to PC4, its human homolog), losing its DNA binding capacity and promoting 
clearance of TFIIB [214-215, 226]. The PIC next changes conformation such that Kin28 can be 
activated, and with the help of Srb10 promotes PIC dissociation into the scaffold complex as 
well as the recruitment of elongating kinases Ctk1 and Bur1. In contrast, in the absence of 
Sub1 (sub1Δ), Srb10 activity and recruitment are decreased, while Kin28 recruitment and 
activity increases, in agreement with TFIIH being negatively regulated by Cdk8-containing 
Mediator complexes [90, 227]. As a result, Ser5P levels are increased, and consequently Bur1 
and Ctk1 association with chromatin is also enhanced [99, 228]. Furthermore, in sub1Δ cells 
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there is a reduction on Fcp1 phosphatase levels and its association with chromatin, which 
induces an additional increase in Ser2P, impairing RNAPII recycling after transcription 
termination. Thus, a decrease in RNAPII recruitment is observed in cells lacking Sub1 [224]. 
Additionally, Sub1 also influences Spt5 elongation factor phosphorylation by Bur1 (García 
and Calvo, unpublished results). We currently do not understand the biochemical basis for 
these effects. We have not found evidence that Sub1 associates with any of the CTD kinases 
or evidence that Sub1 influences the CTD kinase activities by influencing post-translational 
modifications of the kinases. Therefore, we currently consider two possible explanations for 
the effects of Sub1 on the activities of the CTD kinases. One explanation is that Sub1 
enhances the association (or dissociation) of an unidentified, common regulator with the 
kinases, whereas the other is that Sub1 in some manner influences kinase accessibility to the 
CTD. 
 
Figure 5. Model showing how Sub1 might function to globally regulate RNAPII CTD 
phosphorylation [222] . Different font sizes in the figure text indicate the increase or decrease of the 
corresponding CTD modifying enzymes in sub1Δ versus wt cells. 
5. RNAPII CTD phosphorylation and pre-mRNA processing 
The CTD is an unordered structure that extends from the RNAPII core enzyme, near the 
RNA exit channel [204, 209]. This localization is convenient to interact with a plethora of 
factors, such as the CTD-modifying enzymes and binding factors involved in distinct 
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nuclear processes, for example, components of the RNA processing machinery [32, 88]. 
Furthermore, its length and the ability to adopt numerous conformations permit it to 
interact with different factors at the same time [31-32], and it is currently clear that  these 
interactions depends on the CTD phosphorylation patterns during the transcription cycle [8, 
21]. 
As transcription progresses the nascent RNA is capped to protect the 5′ end, intron 
sequences are removed, and a polyadenylated tail is added to the 3’ end. Coupling mRNA 
processing to transcription increases processing efficiency and allows multiple regulatory 
pathways to guarantee that only correctly modified mRNAs are exported. For more than a 
decade, numerous studies have provided evidence that the CTD serves as a scaffold for the 
assembly of an enormous variety of protein complexes to coordinate not only transcription 
of non-coding and protein-coding genes [8, 58-62, 64-65], but also pre-mRNA processing [21, 
31-32]: capping [42, 135, 137], splicing [229], and 3’-end cleavage and polyadenylation [42]. 
All of these functions are achieved through the recognition and reading of the CTD code 
during the transcription cycle [6-8, 31]. Thus, co-transcriptional CTD-mediated processing of 
nascent RNA plays a crucial role in both recruitment of RNA processing machineries and 
regulation of their activities. Indeed, a functional CTD is not required for in vitro 
transcription by RNAPII, but it is essential for efficient pre-mRNA processing [42, 230-231]. 
Capping  
The capping reaction consists in the addition of an inverted 7-methylguanosine cap to the 
first RNA residue by a 5'-5' triphosphate bridge. It is a characteristic of all RNAPII 
transcripts and is added to the 5’-end of nascent transcripts when they are only 25-50 bases 
long. The capping complex contains the following three enzymatic activities: RNA 5'-
triphosphatase, guanylyl transferase and RNA (guanine-7) methyltransferase [17, 67]. In 
yeast, these activities are achieved by three enzymes (i.e., Cet1, Ceg1 and Abd1, 
respectively), whereas in metazoans, these activities are performed by two enzymes (i.e., 
HCE and MT) because guanylyl transferase and RNA 5'-triphosphatase are two functionally 
domains of HCE protein [17]. Following Ser5 phosphorylation by TFIIH, the mRNA capping 
complex binds directly and specifically to Ser5P residues through the Ceg1 subunit in yeast 
or the guanylyl transferase domain in metazoans [48, 67, 78, 95, 137]. Furthermore, 
phosphorylated CTD interaction with the capping complex allosterically stimulates the 
capping enzyme activity and in response, enhances early transcription [136, 232]. Because 
the CTD is located near the RNA exit channel, its interaction with the capping complex 
permits its positioning for rapid processing of the mRNA 5’-end as the nascent transcript 
emerges from the polymerase. This is thought to protect the RNA from degradation and 
promote RNAPII to proceed into productive transcription elongation. In fact, by coupling 
capping and early transcription, only capped RNA will be elongated [67, 136, 232-233].  
3’-end processing 
Not only capping and transcription are linked at the 5’-end regions of protein coding-genes, 
but also polyadenylation and transcription termination at the 3’-end regions. In brief, 3’-end 
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processing consists of the following two-step reaction: endonucleolytic cleavage of the pre-
mRNA and subsequent addition of a poly(A) tail [17]. Both enzymatic reactions require a 
functional CTD [42, 230]. In fact, deletion of the CTD or absence of CTD phosphorylation 
negatively affects 3’-end processing [16, 30, 106, 157, 234]. Furthermore, the CTD binds 3′-
end processing factors and stimulates cleavage/polyadenylation in vivo and in vitro [42, 230]. 
The cleavage is achieved by a complex that consists of CstF, CPSF, CF1, and CF2 in higher 
eukaryotes and CF1A, CF1B, and CFII in yeast, whereas the polyadenylation reaction is 
performed by a poly(A) polymerase in both cases [17] . Cleavage/polyadenylation factors 
CPSF and CstF can specifically bind to CTD affinity columns and are copurified with 
RNAPII [42]. In yeast, several 3’-end factors preferentially binds phosphorylated CTD [72, 
106-107, 235]. Furthermore, yeast 3'-end processing factors are recruited depending on Ser2 
phosphorylation by Ctk1 when RNAPII reaches the 3’-end regions of the transcribed genes. 
Therefore, regulation of CTD phosphorylation as the polymerase transcribes facilitates 
coordination of the assembly of the 3′-end processing machinery with transcription [16]. 
Additionally, the polyadenylation signals are required for proper transcription termination 
in mammals and yeast [236-237]. In fact, Rtt103, which is a 3'-end mRNA processing factor, 
interacts with the CTD phosphorylated on Ser2 and recruits a 5’-3’ RNA exonuclease, 
thereby promoting the release of RNAPII from the DNA [238-239]. In summary, Ser5 
phosphorylation by TFIIH kinase (Kin28/Cdk7) is required to recruit the RNA-capping 
machinery to RNAPII [48, 67, 72], whereas Ser2 phosphorylation is required for the 
recruitment of 3’-end processing complexes and for transcription termination [16, 30, 106, 
238-239] (Figure 7). However, it is unknown whether phosphorylation of Ser5 and Ser2 of all 
of the repeats or only some of the repeats is required to enhance capping and 
cleavage/polyadenylation, respectively.  
Ser7 phosphorylation has been functionally related with 3’-end processing of snRNA in 
higher eukaryotes. Human snRNA genes, contrary to protein-coding genes, are not 
polyadenylated, and instead of a poly(A) signal, they contain a conserved 3′ box RNA-
processing element that is recognized by the snRNA gene-specific Integrator RNA 3′ end-
processing complex. This complex binds to RNAPII CTD and links transcription and 3’-end 
processing [63-64, 240-241]. Therefore, in metazoans, Ser7P, in combination with Ser2P, is a 
major determinant for the recruitment of the Integrator complex to snRNA genes during its 
transcription [64, 240-241]. In yeast, the Integrator-like complex recruitment depends on 
Ser7 phosphorylation, the promoter elements and the specialized PIC that binds those 
elements [74]. After promoter escape, the RNA processing complex travels with the 
elongating phosphorylated polymerase up to the 3’-end box at the end of the snRNA 
transcription unit, where it associates with the nascent transcript in a co-transcriptional-
dependent manner.  
Splicing 
As in the case of capping and cleavage/polyadenylation, a number of studies performed in 
vivo and in vitro during the last decades have demonstrated the existence of a functional 
interaction between the transcriptional machinery and the splicing apparatus [21, 242]. 
However, this functional interaction and the underlying mechanism are less accurately 
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understood. The most complex pre-mRNA processing reaction is splicing, which is carried 
out by a large complex, the spliceosome, consisting of at least 150 protein components and 
five snRNAs [242]. The first indication of a coupling between transcription and splicing 
came from studies demonstrating that truncation of the CTD severely altered splicing in 
vitro [42]. Later it was shown that the CTD directly affects splicing, and that a 
phosphorylated CTD is required for the efficient splicing reaction [231, 243]. These data 
provided evidence that an elongating RNAPII with phosphorylated CTD is an active 
component of the splicing reaction. A number of physical links between the phosphorylated 
CTD and the splicing apparatus have been established, and chromatin immunoprecipitation 
analysis have shown that the direct binding of the splicing machinery to the nascent RNA is 
responsible in a large part for the co-transcriptional splicing in yeast and mammals [244-
245]. Hyperphosphorylated, but not hypophosphorylated RNAPII, has been found 
associated with splicing factors and detected in active spliceosomes [246-248]. For instance, 
in yeast, the splicing factor Prp40 binds to phosphorylated CTD [249]; in mammals, Spt6 
binds selectively to the CTD-Ser2P [112], and the spliceosome-associated protein CA150 
interacts with phosphorylated CTD while interacting with the SF1 splicing factor [250-251]. 
Therefore, all these studies led to the idea that the phosphorylated CTD acts as a scaffold, 
binding multiple splicing factors, and directly enhancing the spliceosome assembly. 
Corroborating this idea, a recent study identified a splicing factor, U2AF65, that interacts 
directly with the CTD to activate splicing and likely plays a role in spliceosome assembly 
[242, 252]. Another recent study provided evidence that coupling transcription and splicing 
through CTD phosphorylation can be a regulatory point in the control of gene expression. 
For instance, it has been described that a set of inducible genes can be actively transcribed 
by RNAPII phosphorylated on Ser5, but not on Ser2, under non-inducing conditions, giving 
rise to a full length unspliced transcript. However, after induction, Cdk9 is recruited, 
phosphorylates the CTD on Ser2 and the generated transcript is properly spliced [253]. This 
fact strongly implicates Ser2P as a key in the integration of splicing and transcription. In 
addition to constitutive splicing, functional links between the CTD and alternative splicing 
have also been provided [86]. Thus, it has been suggested that the CTD may regulate the 
choice of alternative exons by increasing the local concentration of splicing factors [229], and 
that possibility participate in the physical modulation of alternative splicing. 
6. RNAPII CTD phosphorylation coordinates transcription to other 
nuclear processes 
6.1. Coupling the CTD code and the histone code 
The nucleosome is the basic element of chromatin and consists of a histone octamer 
composed of two copies of histone 2A (H2A), H2B, H3 and H4, wrapped by 146 bp of DNA 
[254]. The histones carry numerous post-translational modifications, and some of these are 
associated with transcription. In fact, a general view is that histone post-translational 
modifications draw parallel with either positive or negative transcriptional states. 
Numerous discoveries have led to the idea that such modifications regulate transcription 
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either directly by causing structural changes to chromatin (e.g., histone acetylation) or 
indirectly by recruiting protein complexes (e.g., histone methylation) [255-257]. Therefore, 
chromatin not only plays an essential role in packaging the DNA, but also in regulating 
gene expression. Most histone modifications reside in their amino- and carboxy-terminal 
tails, and a few of them in their globular domains. As in the case of CTD phosphorylation, 
where Ser5P triggers Ser2 phosphorylation, some histone modifications mark the deposition 
of another, thus creating a complex epigenetic signal code, the “histone code”, that governs 
chromatin organization and DNA-dependent processes such as transcription. Therefore, the 
histone code is responsible for an active or inactive chromatin state with respect to 
transcription, because it coordinates the recruitment of various chromatin modifying and 
remodeling complexes to regulate chromatin structure and, consequently, transcription 
[258-259]. Because this review focuses on RNAPII CTD phosphorylation, only certain 
histone modifications, which are functionally related to the CTD code and transcription, will 
be discussed. There are excellent reviews that discuss all the histone modifications and their 
roles in different nuclear processes [255, 258, 260-261]. 
Lysine is a key substrate residue because it undergoes many exclusive modifications 
important for transcription regulation (i.e., acetylation, methylation, ubiquitination and 
SUMOylation [255, 261]. The lysine residues can be mono-, di- or trimethylated, and each 
level of modification can result in distinct biological effects. In brief, with respect to 
transcription, acetylation activates and sumoylation appears to be repressive, and both 
modifications may mutually interfere. On the other hand, methylation can have distinct 
effects; thus, lysine 4 in histone H3 (H3K4me3) is trimethylated at the 5’-ends of genes 
during activation, whereas trimethylation of H3K9 occurs in transcriptionally silent regions. 
Arginine residues of H3 and H4 can also be mono- or dimethylated, which activate 
transcription. Serine/threonine phosphorylation of H3 in specific sites also marks activated 
transcription, and ubiquitination of H2B and H2A are associated with active and repressed 
transcription, respectively (reviewed by [255-257]. All histone modifications are removable 
by specific enzymes (e.g., histone deacetylases (HDACs), phosphatases, and ubiquitin 
proteases ([255-257], and references therein). In fact HDACs play important regulatory roles 
during active transcription [262].  
Methylation of H3K4 and K36 are the most well characterized histone modifications with 
roles in active transcription [263], and whose functions are directly linked to RNAPII CTD 
phosphorylation (Figure 6). H3K4 is methylated by the Set1/COMPASS complex, while K36 
is mediated by the Set2 complex. The profile of H3K4 tri-methylation (H3K4me3) strongly 
correlates with the distribution pattern of the RNAPII CTD-Ser5P. It is mainly found around 
the transcriptional start site (TSS) contributing to transcription initiation, elongation and 
RNA processing [264]. Set1 recruitment and H3K4 tri-methylation usually peaks at the 
promoter and 5’ region of a gene, depending on Kin28/Cdk7 activity (Figure 7)  and Paf1 
complex, a RNAPII-associated complex [265], and contributes to transcription initiation, 
elongation and RNA processing [264] [98]. H3K4 mono and di-methylation tend to expand 
along the coding regions compared to try-methylation. On the other hand, H3K36 
methylation by Set2 is observed across the entire coding region with an increase toward the 
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3’-ends of actively transcribed genes. Ctk1 also regulates H3K4 methylation [158, 266]. 
Thereby, differently phosphorylated CTD by Kin28 and Ctk1 is responsible for the 
characteristic distribution of H3K4 tri-methylation in the coding region [158]. In contrast to 
Set1, the recruitment of Set2 and H3K36 methylation depends on a CTD-Ser2P/Ser5P double 
mark (Figure 6), and therefore, on Ctk1 kinase activity [158, 266]. Interestingly, the other 
Ser2 kinase complex, Bur1/2, also promotes Set2 recruitment and assists H3-K36 
methylation, particularly at the 5′ ends of genes and is required for the histone 2B 
ubiquitination activity of the Rad6/Bre1 complex [101, 103, 152]. 
 
Figure 6. Histone H3 tri-, di-, and mono-methylation and acetylation during RNAPII transcription in S. 
cerevisiae. 
H3 acetylation / deacetylation is also relevant during active transcription. Thus, histone 
acetyl and deacetyl transferase complexes (HAT and HDACs, respectively) are recruited to 
the transcriptional machinery during elongation through the interaction with RNAPII. 
Indeed, they modulate histone occupancy in the coding regions of actively transcribed 
genes, and this depends on CTD phosphorylation status [267-268]. HAT acetylates 
nucleosomes promoting nucleosomes eviction and allowing RNAPII to pass through. 
Afterward, the nucleosomes are immediately reassembled behind the polymerase and 
HDACs are co-transcriptionally recruited to rapidly and efficiently deacetylate the 
reassembled nucleosomes behind the polymerase. Altogether, this avoids cryptic 
transcription and maintains active transcription [262]. Methylation of histone H3 by Set1 
and Set2 is required for deacetylation of nucleosomes in coding regions by the histone 
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deacetylase complexes (HDACs) Set3C and Rpd3C(S), respectively. HDACs’ recruitment is 
triggered by H3K4 methylation at promoters and within coding regions to restrict 
hyperactetylated histones to promoters and to maintain transcription activity. Set1-
H3K4me2 can be recognized by two different HDACs, RPD3S or SET3C [264]. The Set1-
SET3C pathway preferentially affects actively transcribed genes with promoters configured 
for efficient initiation/re-initiation [269]. In contrast, Set1-RPD3S pathway is active at loci 
subjected to cryptic and weak transcription encompassing repressed promoters of coding 
genes. Related to this, phosphorylation of the CTD by Kin28/Cdk7 is important for the initial 
recruitment of the Rpd3S and Set3 HDACs to coding sequences ([268], Figure 7). In fact, it 
has been reported that Set3C and Rpd3C(S) are co-transcriptionally recruited in the absence 
of Set1 and Set2, but stimulated by the CTD kinase Kin28/Cdk7. Hence, the Rpd3C(S) and 
Set3C co-transcriptional recruitment is stimulated by CTD Ser5P to achieve the 
deacetylation of H3 residues. This, together with evidence that the RNAPII CTD recruits 
additional chromatin modifying complexes, histone chaperones and elongation factors, 
suggest that phosphorylated RNAPII is crucial in coordinating the activities of the many 
factors required for regulating histone dynamics and consequently transcription elongation 
at actively transcribing genes ([262], and references therein).  
6.2. Transport 
In addition to the complexes involved in mRNA processing, several other proteins bind to 
the RNAs as soon as their 5’-end emerges from the RNAPII, packaging them into a 
messenger ribonucleoparticle (mRNP). This set of interactions of packaging and export 
factors play a dual function of protecting the RNA from degradation and preparing it to be 
exported. Although interactions between the CTD and many mRNA processing factors have 
been characterized, this is not the case for mRNA packaging and export factors. However, 
packaging and export seems to be also coupled to transcription through RNAPII CTD 
interactions because defects in transcription elongation, splicing, and 3′-end processing 
affect export [270]. In yeast, mRNA export is linked to transcription through the TREX 
(transcription export) complex, which is composed of the THO complex (Tho2, Hpr1, Mft1, 
and Thp2) and the evolutionally conserved RNA export proteins, Sub2 (UAP56 in human) 
and Yra1 (REF/Aly in human), and a novel protein termed Tex1 [271-272]. Deletions of the 
individual THO components causes defects on transcription, transcription-dependent 
hyper-recombination, and on mRNA export [160, 273]. In addition, the Sub2/Yra1 complex 
is directly recruited to the actively transcribed regions via the THO complex [272, 274]. 
Although it has been shown that the TREX complex and Ctk1 are functionally related [159], 
recruitment of the TREX complex to transcribed genes is not dependent on Ctk1 in yeast 
[16], and the association of the human TREX complex to transcript might be coupled to 
transcription indirectly through splicing [275]. Then, the potential role of the CTD and CTD 
phosphorylation in this process remains unclear, however in a very recent study, the mRNA 
export factor Yra1 was identified as a CTD phosphorylated-binding protein [276]. Then, this 
study provides strong support for the idea that the phosphorylated CTD is directly involved 
in the cotranscriptional recruitment of export factors to active genes. In summary, many 
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aspects of the mRNA metabolism from the 5' capping to the export occur co-
transcriptionally and are coordinated through transcription, with the RNAPII CTD and its 
phosphorylation being the main coordinator in most cases (Figure 7). 
 
Figure 7. RNAPII CTD phosphorylation/ de-phosphorylation is co-transcriptionally connected and 
coordinated with other nuclear processes: pre-mRNA processing; histone modifications and mRNA 
export. The main complexes required for co-transcriptional processes occurring during the expression 
of a regular protein coding-gene are shown. See text for details.  
7. RNAPII CTD phosphorylation and transcription regulation 
The levels of CTD phosphorylation/de-phosphorylation are precisely modulated during the 
entire transcription cycle, which regulates the association of many important factors with 
initiating and elongating RNAPII, such as transcription and pre-mRNA processing factors, 
chromatin modifiers and mRNA export factors [21]. The interplay of all of these factors is 
essential to regulating transcription and, consequently, gene expression. Subsequently, in a 
regular protein-coding gene, the following set of coordinated nuclear events must occur for 
it to be properly transcribed in a functional mRNA before it is exported to the cytoplasm 
and translated (Figure 7). Unphosphorylated RNAPII is recruited to the pre-initiation 
complex (PIC); then, after its binding to the promoters, it is phosphorylated on Ser5 by 
yKin28 (hCdk7). Ser5 phosphorylation is required for RNAPII dissociation from the PIC and 
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consequently promotes transcription initiation. Simultaneously, Ser5 phosphorylation 
targets capping and splicing factor recruitment, the Set1 methyltransferase complex, and the 
Set3C and Rpd3S histone deacetylase complexes. During early elongation, Ser5P levels are 
decreased, whereas Ser2P levels increase due to the kinase activity of yBur1 (hCdk9) near 
the promoters, and by the kinase activity of yCtk1 (hCdk12) at the forward coding and 3’-
ends, which leads to the recruitment of the histone methyltransferase Set2 and the activation 
of the Rpd3S complex, which prevents cryptic transcription within the genes. When RNAPII 
arrives at and recognizes the termination site, the 3’-end-processing factors that are 
associated with the CTD achieve cleavage and polyadenylation of the nascent mRNA, which 
also requires proper phosphorylation of the polymerase. During the termination process, the 
CTD is de-phosphorylated by Ssu72 and Fcp1, and the polymerase is recycled to initiate a 
new round of transcription. All along the gene, packaging and export factors (TREX 
complexes) are incorporated into the transcriptional machinery protecting the transcript 
from degradation and preparing it for export to the cytoplasm. 
8. Therapeutic potential 
Cellular differentiation, morphogenesis, development and adaptability of all organisms are 
subjected to proper gene expression and, therefore, variations in gene regulation can have 
profound effects on protein function, challenging the viability of the organisms. Currently, it 
is clear that RNAPII phosphorylation has an important role on gene expression, and 
therefore, in all the processes mentioned above. Consequently, over the last decade CTD 
phosphorylation has attracted the attention of biomedical research, especially due to the fact 
that the CTD kinase Cdk9 has been involved in several physiological cell processes, whose 
deregulation may be associated with cancer, and also due to the fact that Cdk9 activity is 
required for human immunodeficiency virus type 1 (HIV-1) replication. Related to it, many 
studies have shown the enormous potential of Cdk9 kinase inhibition as a treatment of 
several kinds of tumors, HIV infection, and cardiac hypertrophy. 
The human immunodeficiency virus type 1 (HIV-1) requires host cell factors for all steps of 
the viral replication, among them the transcription elongation factor P-TEFb. Transcription 
of HIV-1 viral genes is achieved by host RNAPII and is induced by a viral trans-activator 
protein, Tat. When bound to the TAR viral RNA region, Tat activates HIV-1 transcription by 
early recruiting of host transcriptional activators including P-TEFb, which phosphorylates 
RNAPII CTD promoting viral transcript elongation [280]. Thus, treatment with drugs that 
inhibit Cdk9, such as flavopiridol, has been used as a retroviral therapy on AIDS patients 
[281]. Therefore, from the point of view of basic research, the study of the functions of Cdk9 
and RNAPII CTD phosphorylations are of great interest in understanding the mechanisms 
that regulate HIV replication, which consequently lead to progress on AIDS biomedical 
research. Further evidence has been provided of a deregulated Cdk9 function in several 
tumors such as lymphoma, neuroblastoma, primary neuroectodermal tumor, 
rhabidomiosarcoma or prostate cancer [282-284]. The Cdk9 inhibition by chemotherapeutic 
agents, such as flavopiridol or CY-202, has shown to reduce transcription in malignant cells, 
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mainly affecting the short half-lives RNAs. Most of these RNAs code for anti-apoptotic 
proteins, for instance onco-protein Mcl-1, which is necessary in tumor proliferation 
maintenance. Unfortunately, they only have a modest activity in patients although 
promising studies continue at present [285]. Cardiac hypertrophy consists of an increased 
size of cardiomyocytes, associated to some cardiac diseases as hypertension or diminished 
heart function. Hypertrophy is a physiological response to a stress stimulus that results in 
an increase of the cell size, and that may eventually produce a heart failure. Increased cell 
size produces increased mRNAs transcription, which requires Cdk9 activity. Thus, it has 
been shown that therapy with Cdk9 inhibitors benefits patients with cardiovascular 
disorders [286]. 
9. Concluding remarks 
The primary function of the RNAPII CTD phosphorylation in eukaryotes is the integration 
of transcription with distinct nuclear processes. Thus, CTD phosphorylation operates as a 
fine-tuning regulatory mechanism during the whole transcription cycle and is consequently 
of extraordinary importance for proper gene expression. Since the late 1980’s, an 
overwhelming number of laboratories have tried to decipher the mechanism underlying the 
creation of a CTD code and how this code is translated during transcription to coordinate 
mRNA processing, export and chromatin modifications. Although great progress has been 
achieved, most recently due to wide-genomic analysis techniques, a number of issues 
remained unsolved. For instance, it is very challenging to determine the exact 
phosphorylation state of specific residues within specific repeats during each step of 
transcription, as well as to determine the exact number of repeats that are phosphorylated 
within the CTD at every step of transcription, and how this is related to CTD specific roles 
in gene expression. Moreover, it needs to be determined if phosphorylation of the repeats 
with non-consensus sequences is regulated in the same manner as the consensus repeats, 
and if this is achieved by the same set of CTD modifying enzymes. In addition, other 
residues such as lysine and arginine can be potentially modified; therefore, further 
increasing the complexity of the CTD, and suggesting that if they are transcriptionally 
modified, may further elucidate the CTD functions or discover new ones. Finally, detailed 
understanding of RNAPII CTD phosphorylation is very relevant and will add insight into 
the processes that alter gene expression, such as HIV infection and cancer, and will help to 
investigate if other human CTD modifying enzymes, in addition to Cdk9, may be good 
candidates for therapy. In conclusion, research has made much progress, but further 
progress is still needed, and the new massive techniques in genomics and proteomics will 
help to advance complete understanding much faster. 
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